0
Article Tier 2 Sign in to save

Environmental Pollutant–Induced Cardiopathogenesis Through Immune Dysfunction: The Emerging Role of Micro- and Nanoplastics

AI summary Read the abstract

Researchers reviewed experimental and clinical evidence linking micro- and nanoplastic exposure to cardiovascular disease, showing that MNPs detected in human vascular and cardiac tissues promote macrophage inflammation, disrupt endothelial barriers, activate NLRP3 inflammasome signaling, and amplify oxidative stress — converging mechanisms that increase vulnerability to atherosclerosis, arrhythmia, and ischemic injury.

Exposure to environmental pollutants and toxicants is increasingly recognized as a major determinant of cardiovascular disease. Beyond direct toxic effects, these agents profoundly alter immune homeostasis, and thereby contribute to endothelial dysfunction, atherogenesis, arrhythmogenesis, and impaired myocardial repair. Among emerging pollutants, micro- and nanoplastics (MNPs) have recently gained attention because of their ubiquity and potential cardiovascular effects. In this narrative review we synthesize mechanistic, translational, and clinical evidence on pollutant-induced cardiovascular injury mediated by immune dysfunction. We integrate data from experimental models, human tissue studies, and clinical observations to delineate shared and pollutant-specific immunoinflammatory pathways, with a particular focus on MNPs. Environmental toxicants, including particulate matter, heavy metals, endocrine disruptors, and MNPs promote chronic innate immune activation, mitochondrial stress responses, NLRP3 inflammasome signalling, and maladaptive epigenetic reprogramming of myeloid cells. MNPs have been detected in human cardiovascular tissues and are associated with adverse cardiovascular events. Experimental evidence indicates that MNPs accumulate within vascular and cardiac compartments, disrupt endothelial barrier integrity, enhance macrophage proinflammatory polarization, and amplify oxidative and nitrosative stress. These converging mechanisms foster plaque vulnerability, microvascular instability, and increased susceptibility to ischemic and arrhythmic complications. Environmental cardiopathogenesis represents a rapidly expanding frontier in cardioimmunology. Elucidating the immune-mediated mechanisms that link pollutant exposure-particularly MNPs-to cardiovascular injury might improve risk stratification and inform targeted preventive and therapeutic strategies in increasingly polluted environments.

More Papers Like This

Article Tier 2

02 | Micro- and Nanoplastics: a New Unconventional Risk Factor for Cardiovascular Health

AI summary Read the abstract

Researchers reviewed growing clinical and experimental evidence that micro- and nanoplastics can act as non-conventional cardiovascular risk factors, with MNPs detected directly within atherosclerotic plaques where their presence correlates with enhanced inflammatory activity, plaque instability, and worse cardiovascular outcomes—suggesting MNPs amplify established cardiometabolic risks through oxidative stress and endothelial dysfunction.

Article Tier 2

Micro(nano)plastics in the Development of Myocardial Fibrosis: From Clinical Detection to Molecular Mechanism

AI summary Read the abstract

Researchers found that micro- and nanoplastic burden in human cardiac tissue—particularly nanoplastics—was positively associated with myocardial fibrosis severity, and confirmed in mice that polystyrene nanoplastic exposure worsens stress-induced cardiac remodeling by activating inflammatory, extracellular matrix, and metabolic pathways.

Article Tier 2

Microplastics and Nanoplastics in Cardiovascular Disease: An Emerging Cardiovascular Risk Factor

AI summary Read the abstract

Researchers reviewed mounting experimental and early clinical evidence that microplastics and nanoplastics cross epithelial barriers, accumulate in arterial plaques, cardiac tissue, and thrombi, and trigger oxidative stress and coagulation dysregulation, framing these particles as an emerging cardiovascular risk factor that warrants integration into disease prevention frameworks.

Article Tier 2

Emerging cardiovascular risks of micro- and nanoplastics: toxic effects and mechanistic pathways

AI summary Read the abstract

Tiny plastic particles called micro- and nanoplastics are getting into our bodies through food, air, and skin contact, and researchers have found them building up in people's hearts and blood vessels. This review of existing studies shows these plastic bits may contribute to heart disease by causing inflammation and damaging cells in the cardiovascular system. While more research is needed, this suggests that plastic pollution isn't just an environmental problem—it could be directly harming our heart health.

Article Tier 2

Micro and Nano-plastic particles: What are they and do they effect cardiovascular health?

AI summary Read the abstract

This review examines the cardiovascular health effects of micro- and nanoplastics, summarizing evidence that these particles have been detected in human tissues including arterial plaques and may promote endothelial dysfunction and inflammation. The authors call for further clinical and epidemiological research into cardiac risk.

Research digests by email

When a large batch of papers lands in the Atlas, we read through it and send a short write-up of what stood out.

Email me about

Share this paper